Oxipurinol (XORTX Therapeutics)

N/A

Report date: 2025/12/05 16:14:42

Base Information

Drug NameOxipurinol (XORTX Therapeutics)
Drug Alias NameOxypurinolXORLOXRx-008XRx-101XRx-026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsAcute Kidney InjuryPolycystic Kidney DiseasesGout
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesXortx Therapeutics
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAcute Kidney InjuryPolycystic Kidney DiseasesGout
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A